301 related articles for article (PubMed ID: 2869139)
1. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
2. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
[TBL] [Abstract][Full Text] [Related]
4. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin-sensitive adenylate cyclase of a murine macrophage-like cell line (P388D1): II. Isolation and partial characterization of PGE2-binding proteins.
Fernandez-Botran R; Suzuki T
J Immunol; 1984 Nov; 133(5):2662-7. PubMed ID: 6090536
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 binding sites in bovine iris-ciliary body.
Bhattacherjee P; Csukas S; Paterson CA
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1109-13. PubMed ID: 2162336
[TBL] [Abstract][Full Text] [Related]
8. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
Miller OV; Gorman RR
J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
[TBL] [Abstract][Full Text] [Related]
9. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
10. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
Eggerman TL; Hartzell CJ; Selfe S; Andersen NH
Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]-prostaglandin E2 binding to prostaglandin EP4 receptors expressed with Semliki Forest virus.
Marshall FH; Patel K; Lundstrom K; Camacho J; Foord SM; Lee MG
Br J Pharmacol; 1997 Aug; 121(8):1673-8. PubMed ID: 9283702
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
Cooper B; Ahern D
J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for the presence of selective binding sites for (3H) prostaglandin E2 on rat peritoneal macrophages.
Opmeer FA; Adolfs MJ; Bonta IL
Biochem Biophys Res Commun; 1983 Jul; 114(1):155-61. PubMed ID: 6136274
[TBL] [Abstract][Full Text] [Related]
15. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization and autoradiographic localization of [3H]PGE2 binding sites in rat kidney.
Eriksson LO; Larsson B; Andersson KE
Acta Physiol Scand; 1990 Jul; 139(3):405-15. PubMed ID: 2173351
[TBL] [Abstract][Full Text] [Related]
18. The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue.
Chegini N; Rao CV
J Clin Endocrinol Metab; 1988 Jan; 66(1):76-87. PubMed ID: 2826530
[TBL] [Abstract][Full Text] [Related]
19. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
20. Specific prostaglandin E2 binding sites in isolated rat glomeruli: evidence for glomerular PGE receptors.
Chaudhari A; Kirschenbaum MA
Prostaglandins Leukot Med; 1985 Oct; 20(1):55-68. PubMed ID: 2866541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
